# The RADAR Study - Wearable-Based Dysglycemia Detection and Warning in Diabetes

> **NCT04689685** · — · COMPLETED · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 40 (actual)

## Conditions studied

- Diabetes Mellitus, Insulin-Dependent
- Diabetes

## Interventions

- **OTHER:** Wearing smartwatch and continous glucose sensor

## Key facts

- **NCT ID:** NCT04689685
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-19
- **Primary completion:** 2022-03-28
- **Final completion:** 2022-03-28
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2022-09-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04689685

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04689685, "The RADAR Study - Wearable-Based Dysglycemia Detection and Warning in Diabetes". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04689685. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*